This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Calchan Limited, Convergence Pharmaceuticals Limited. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Ghislaine Lorthioir: Innovator in Pharmaceutical Chemistry
Introduction
Ghislaine Lorthioir is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on pyrrolopyrimidine derivatives. With a total of 2 patents to her name, Lorthioir's inventions have the potential to impact the pharmaceutical industry positively.
Latest Patents
Lorthioir's latest patents include the development of ASK1 inhibiting pyrrolopyrimidine derivatives. This invention relates to pyrrolopyrimidine derivatives of formula (I), where R, X, p, R, and R are defined within the patent documentation. These derivatives are being explored for their use as pharmaceuticals, showcasing Lorthioir's commitment to advancing medical science.
Career Highlights
Throughout her career, Ghislaine Lorthioir has worked with various companies, including Convergence Pharmaceuticals Limited and Calchan Limited. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Lorthioir has collaborated with notable professionals, including David Witty and David Norton. These partnerships have further enriched her work and expanded the scope of her inventions.
Conclusion
Ghislaine Lorthioir is a pioneering inventor whose work in pharmaceutical chemistry continues to influence the industry. Her innovative patents and collaborations highlight her dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
